News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Cue Biopharma and ImmunoScape form strategic partnership to develop new cell therapy for solid tumours
Friday, November 07, 2025Cue Biopharma Inc a clinicalstage biopharmaceutical company focused on developing targeted Tcell therapies for autoimmune diseases and cancer has entered into a collaboration and licence agreement with ImmunoScape Pte
Pharming Group Reports Strong Q3 2025 Revenue Growth, Strategic Refocus and Pipeline Advances in Rare Disease Segment
Thursday, November 06, 2025Pharming Group reported significant revenue and profitability growth in Q announced a strategic withdrawal from nonUS RUCONEST markets pipeline progress for leniolisib and key leadership changes to bolster its global rare disease focus
Jupiter Neurosciences Receives U.S. FDA Clearance to Begin Phase 2a Trial of JOTROL™ for Parkinson’s Disease
Thursday, November 06, 2025Jupiter Neurosciences Inc a clinicalstage pharmaceutical company developing JOTROL a patented resveratrolbased therapeutic platform targeting neuroinflammation and mitochondrial dysfunction
Moberg Pharma and Karo Healthcare Forge Exclusive License to Launch MOB-015 (Terclara®) Across 19 European Markets
Wednesday, November 05, 2025Moberg Pharma and Karo Healthcare have signed an exclusive agreement to commercialize MOB Terclara across key European markets under the Lamisil brand establishing a new frontrunner in the antifungal therapeutics arena
Boehringer Ingelheim and CDR-Life Sign Global Licensing Agreement for CDR111, a Trispecific Antibody for Autoimmune Diseases
Wednesday, November 05, 2025Boehringer Ingelheim and CDRLife Inc have entered into a global licensing agreement to develop CDR a trispecific antibodybased molecule designed for the treatment of autoimmune diseases
Eli Lilly Unveils $3 Billion Manufacturing Facility in Netherlands, Marking Major Investment in European Pharma Supply Chain
Tuesday, November 04, 2025Eli Lilly announces a billion investment in a new oral medicines manufacturing facility at Leiden Bio Science Park Netherlands enhancing its European production and supply chain capabilities
Cosmo Pharmaceuticals Receives CE Certification for ColonPRO EU, Europe’s Most Advanced AI Colonoscopy Platform
Monday, November 03, 2025Cosmo Pharmaceuticals has received CE certification for ColonPRO EU marking a major leap in AIpowered colonoscopy across Europe
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Saturday, November 01, 2025Calluna Pharma AS a clinicalstage biotechnology company focused on developing novel antibodies for inflammatory and fibrotic diseases has received Orphan Drug Designation from the US Food and Drug Administration FDA for CAL
